In addition to the regulation of glycolysis, mutant KRAS signaling stimulates mitochondrial translocation of phosphoglycerate kinase 1 (PGK1), leading to phosphorylated PDHK1 and restricted OXPHOS in pancreatic cancer cells [46]. Here, KRAS is linked to pancreatic neoplasm.